Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only.
- Positions
- 17
- No filing for Q3 2023
- Portfolio value
- $143.3M
- No filing for Q3 2023
Checkpoint Capital L.P. did not file a 13F for Q3 2023, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | COM | 730,000 | $33.6M | 23.4% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 70,000 | $26.6M | 18.6% | – | – | History |
| CYTKCytokinetics Inc | COM NEW | 230,000 | $19.2M | 13.4% | – | – | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 340,000 | $12.4M | 8.7% | – | – | History |
| AXSMAxsome Therapeutics, Inc. | COM | 155,346 | $12.4M | 8.6% | – | – | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 880,000 | $10.1M | 7.0% | – | – | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 233,659 | $6.90M | 4.8% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 266,856 | $6.12M | 4.3% | – | – | History |
| AVDLAvadel Pharmaceuticals PLC | SPONSORED ADR | 325,000 | $4.59M | 3.2% | – | – | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 359,446 | $3.28M | 2.3% | – | – | History |
| ATYRaTYR PHARMA INC | COM NEW | 1,503,554 | $2.12M | 1.5% | – | – | History |
| TRVITrevi Therapeutics, Inc. | COM | 1,292,316 | $1.73M | 1.2% | – | – | History |
| GHRSGH Research PLC | ORDINARY SHARES | 293,945 | $1.70M | 1.2% | – | – | History |
| ALLKAllakos Inc. | COM | 444,804 | $1.21M | 0.8% | – | – | History |
| IRONDisc Medicine, Inc. | COM | 10,000 | $577.6K | 0.4% | – | – | History |
| ACRSAclaris Therapeutics, Inc. | COM | 453,614 | $476.3K | 0.3% | – | – | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 33,000 | $361.0K | 0.3% | – | – | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $16.1M | – |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | – | $5.72M |